EUCTR2016-001878-15-Outside-EU/EEA进行中（未招募）1 期
Single and Multiple Dose Pharmacokinetics and Safety Study of Rabeprazole Sodium in 12 to 16 Year Old Subjects
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Males and females age 12 to 16 years, with a clinical diagnosis of, or symptoms of, GERD.
- •2. Subjects had to be able and willing to take the required number of test drug tablets.
- •3. The ability of the child to swallow an intact tablet had to be confirmed by the site at screening by history taking.
- •4. Minimum weight of 30 kg.
- •5. Willingness of the subject and ability to give assent to participate.
- •6. The subject's parent or guardian provided written informed consent.
- •7. Post-pubertal females were required to abstain from sexual relations during the course of the study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 24
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Evidence of significant hepatic, renal, respiratory, endocrine, hematologic, neurologic, psychiatric or cardiovascular system abnormalities, unless the Sponsor and Investigator agreed that the nature and severity of any abnormality was unlikely to interfere with the conduct of the study, the interpretation of study results, or the health of the subject during the study.
- •2. Females who were pregnant, lactating or had a positive urine beta-human chorionic gonadotropin (hCG) laboratory result.
- •3. Subjects who were unwilling or unable to refrain from smoking or drinking alcohol starting from 48 hours prior to screening and dosing, through the end of the study, and/or a positive urine drug screen.
- •4. Subjects who were unwilling or unable to abide by the requirements of the study or who violated the prohibitions and restrictions of the study defined in the Study Protocol.
- •5. Any condition, which in the opinion of the Investigator or Sponsor, would make the subject unsuitable for the study.
- •6. Participation in another investigational drug study within 30 days prior to drug administration.
- •7. A subject history of drug allergies or sensitivity to proton pump inhibitors or to their inactive ingredients.
- •8. A subject history of clinically significant bacterial or viral infection within one month of screening.
- •9. Subject history of definitive acid-lowering surgery or previous esophageal or gastric surgery, with the exception of a simple closure of a perforated ulcer.
研究者
相似试验
进行中（未招募）
1 期
A research project to find out how safe and effective a single dose of TAK-491 research medicine is, after it has been taken by children aged 6 months – 16 years who have high blood pressure. Healthy adults will also be included in this research project to provide a comparison.HypertensionEUCTR2009-013165-25-GBTakeda Development Centre Europe Ltd.29
进行中（未招募）
不适用
A research project to find out how safe and effective a single dose of TAK-491 research medicine is, after it has been taken by children aged 6 months – 16 years who have high blood pressure. Healthy adults will also be included in this research project to provide a comparison.MedDRA version: 14.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 14.1Level: PTClassification code 10015488Term: Essential hypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2009-013165-25-Outside-EU/EEATakeda Global Research & Development Centre (Europe) Ltd.32
进行中（未招募）
不适用
The pharmacokinetics of single and multiple doses of intravenous paracetamol in children - Pharmacokinetics of I.V paracetamol in childreThere is no medical condition to be investigated. This is a pharmacokinetic study to be performed in children routinely treated with intravenous paracetamol for post surgical pain in line with local treatment protocol.EUCTR2009-012585-30-GBHS Grampian Research and Development
进行中（未招募）
不适用
The pharmacokinetics of single and multiple doses of intravenous ketorolac in children - Pharmacokinetics of I.V Ketorolac in ChildreThere is no medical condition being investigated. This is a pharmacokinetic study to be performed in children routinely treated with ketorolac for post surgical pain in line with local treatment protocols.EUCTR2009-012512-41-GBHS Grampian
进行中（未招募）
1 期
Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects/A submitted trial is conducted on healthy subjectsMedDRA version: 21.1Level: PTClassification code: 10036312Term: Post-traumatic epilepsy Class: 100000004852MedDRA version: 22.1Level: PTClassification code: 10076982Term: Post stroke epilepsy Class: 100000004852CTIS2023-506633-30-00Pikralida Sp. z o.o.12